President Obama’s appointee just sailed through the approval process, and has been approved as the next FDA Commissioner. What does this mean now that Robert Califf, known for having financial ties with Gambro, Regeneron, Gilead, AstraZeneca, Roche and other companies, but who is also equally in equity positions in four medical companies? It means the FDA has officially been bought by Big Pharma.
Big Pharma won big today when the Senate nearly unanimously approved Dr. Robert Califf as the next commissioner of the Food and Drug Administration (FDA). And not everyone is happy about it.
Califf was confirmed for the job in a vote of 89 to 4 after weeks of opposition from a handful of senators, including presidential candidate Bernie Sanders, who had attempted to block the longtime cardiologist and academic researcher. [1]
Obama's new FDA appointee may be the greatest example of Washington's corporate-government revolving door yet.The post Obama’s New Appointee to Head the FDA Is a Big Pharma Mega-Lobbyist appeared first on The Anti-Media.
